Cargando…

Drug-induced expression of EpCAM contributes to therapy resistance in esophageal adenocarcinoma

BACKGROUND: With a less than 5% overall survival rate, esophageal adenocarcinoma (EAC) is one of the leading causes of death in the United States. Epithelial cell adhesion molecule (EpCAM) is a cancer stem cell (CSC) marker that is expressed in various epithelial carcinomas, including EAC. Accumulat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Xuan, Martin, Robert C. G., Zheng, Qianqian, Farmer, Russell, Pandit, Harshul, Li, Xuanyi, Jacob, Kevin, Suo, Jian, Li, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2018
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244739/ https://www.ncbi.nlm.nih.gov/pubmed/30116994 http://dx.doi.org/10.1007/s13402-018-0399-z

Ejemplares similares

Carcinogenetic initiation contributed by EpCAM+ cancer cells in orthotopic HCC models of immunocompetent and athymic mice
por: Pandit, Harshul, et al.
Publicado: (2020)

The detection of EpCAM(+) and EpCAM(–) circulating tumor cells
por: Wit, Sanne de, et al.
Publicado: (2015)

Expression of EpCAM(MF) and EpCAM(MT) variants in human carcinomas
por: Fong, Dominic, et al.
Publicado: (2014)

EpCAM expression in esophageal cancer and its correlation with immunotherapy of solitomab
por: Yu, Lan, et al.
Publicado: (2021)

Expression of EpCAM in uveal melanoma
por: Odashiro, Danilo N, et al.
Publicado: (2006)

Biology and clinical relevance of EpCAM
por: Keller, Laura, et al.
Publicado: (2019)

EpCAM as Modulator of Tissue Plasticity
por: Fagotto, François
Publicado: (2020)

EpCAM(high) and EpCAM(low) circulating tumor cells in metastatic prostate and breast cancer patients
por: de Wit, Sanne, et al.
Publicado: (2018)

EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex
por: Subramanian, Nithya, et al.
Publicado: (2015)

Current View on EpCAM Structural Biology
por: Gaber, Aljaž, et al.
Publicado: (2020)

Evolution of Thyroglobulin Loop Kinetics in EpCAM
por: Chen, Serena H., et al.
Publicado: (2021)

EpCAM expression in squamous cell carcinoma of the uterine cervix detected by monoclonal antibody to the membrane-proximal part of EpCAM
por: Chantima, Warangkana, et al.
Publicado: (2017)

Correction to: EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex
por: Subramanian, Nithya, et al.
Publicado: (2020)

Functions of EpCAM in physiological processes and diseases (Review)
por: Huang, Li, et al.
Publicado: (2018)

EpCAM Knockdown Alters MicroRNA Expression in Retinoblastoma- Functional Implication of EpCAM Regulated MiRNA in Tumor Progression
por: Beta, Madhu, et al.
Publicado: (2014)

EpCAM Immunotherapy versus Specific Targeted Delivery of Drugs
por: Macdonald, Joanna, et al.
Publicado: (2018)

EpCAM proteolysis: new fragments with distinct functions?
por: Schnell, Ulrike, et al.
Publicado: (2013)

EpCAM and the biology of hepatic stem/progenitor cells
por: Dollé, Laurent, et al.
Publicado: (2014)

Targeting EpCAM (CD326) for immunotherapy in hepatoblastoma
por: Armeanu-Ebinger, Sorin, et al.
Publicado: (2013)

Revisiting the Roles of Pro-Metastatic EpCAM in Cancer
por: Mohtar, M. Aiman, et al.
Publicado: (2020)

Correction: EpCAM Knockdown Alters MicroRNA Expression in Retinoblastoma- Functional Implication of EpCAM Regulated MiRNA in Tumor Progression
Publicado: (2015)

EpCAM (CD326) finding its role in cancer
por: Baeuerle, P A, et al.
Publicado: (2007)

EpCAM (CD326) finding its role in cancer
por: Baeuerle, P A, et al.
Publicado: (2007)

Expression of EpCam and Villin in Barrett’s Esophagus and in Gastric Cardia
por: Anders, Mario, et al.
Publicado: (2008)

Selection and targeting of EpCAM protein by ssDNA aptamer
por: Alshaer, Walhan, et al.
Publicado: (2017)

Clinicopathology of EpCAM and EGFR in Human Epithelial Ovarian Carcinoma
por: Zheng, Jingying, et al.
Publicado: (2017)

EpCAM(low) Circulating Tumor Cells: Gold in the Waste
por: Nicolazzo, Chiara, et al.
Publicado: (2019)

EpCAM tumor specificity and proteoform patterns in urothelial cancer
por: Dressler, Franz F., et al.
Publicado: (2023)

Imaging-Guided Therapy Simultaneously Targeting HER2 and EpCAM with Trastuzumab and EpCAM-Directed Toxin Provides Additive Effect in Ovarian Cancer Model
por: Xu, Tianqi, et al.
Publicado: (2021)

EpCAM as a Novel Biomarker for Survivals in Prostate Cancer Patients
por: Liao, Yang, et al.
Publicado: (2022)

Construction, Expression, and Characterization of a Recombinant Immunotoxin Targeting EpCAM
por: Lv, Minghua, et al.
Publicado: (2015)

Circular RNA profile in liver tissue of EpCAM knockout mice
por: Yang, Yanhong, et al.
Publicado: (2019)

An anti-EpCAM antibody EpAb2-6 for the treatment of colon cancer
por: Liao, Mei-Ying, et al.
Publicado: (2015)

Activator protein 1 (AP-1) contributes to EpCAM-dependent breast cancer invasion
por: Sankpal, Narendra V, et al.
Publicado: (2011)

EpCAM-claudin-tetraspanin-modulated ovarian cancer progression and drug resistance
por: Tavsan, Zehra, et al.
Publicado: (2020)

Characterization of human anti-EpCAM antibodies for developing an antibody–drug conjugate
por: Satofuka, Hiroyuki, et al.
Publicado: (2023)

CRISPR/Cas9 disruption of EpCAM Exon 2 results in cell-surface expression of a truncated protein targeted by an EpCAM specific T cell engager
por: Bagheri, Andisheh, et al.
Publicado: (2022)

EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis
por: Spizzo, Gilbert, et al.
Publicado: (2011)

Initial activation of EpCAM cleavage via cell-to-cell contact
por: Denzel, Sabine, et al.
Publicado: (2009)

Effects of EpCAM overexpression on human breast cancer cell lines
por: Gostner, Johanna M, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ho8k71qttnpip78v1j4deuaspm